BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34887139)

  • 1. Treatment of alopecia areata with Diphenylcyclopropenone: methodology based on the principles of allergic contact dermatitis.
    Lopes ASA; Lazzarini R
    An Bras Dermatol; 2022; 97(1):125-127. PubMed ID: 34887139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of alopecia areata with diphenylcyclopropenone.
    Kietzmann H; Hardung H
    Acta Derm Venereol; 1985; 65(3):274-5. PubMed ID: 2411093
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of alopecia areata with diphenylcyclopropenone.
    Hull SM; Cunliffe WJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):276-7. PubMed ID: 1552076
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
    Napolitano M; Cantelli M; Vastarella M; Nappa P; Fabbrocini G; Patruno C
    Contact Dermatitis; 2019 Jul; 81(1):67-68. PubMed ID: 30663070
    [No Abstract]   [Full Text] [Related]  

  • 7. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired hair curling after diphenylcyclopropenone immunotherapy in alopecia areata patient.
    Choe SJ; Kim BJ; Choi J; Lee WS
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):e371-e372. PubMed ID: 28191673
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 10. Diphenylcyclopropenone for alopecia areata: a U.K. survey.
    Karanovic S; Harries M; Kaur MR
    Br J Dermatol; 2018 Aug; 179(2):514-515. PubMed ID: 29480935
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema Multiforme Major After Immunotherapy With Diphenylcyclopropenone for Alopecia Areata.
    Sanger J; Zahir A; Driscoll M; Gaspari AA
    Dermatitis; 2018; 29(6):348-349. PubMed ID: 30346328
    [No Abstract]   [Full Text] [Related]  

  • 13. Chinese experience in the treatment of alopecia areata with diphenylcyclopropenone.
    Pan R; Liu J; Xuan X; Li B
    J Dermatol; 2015 Feb; 42(2):220-1. PubMed ID: 25545114
    [No Abstract]   [Full Text] [Related]  

  • 14. Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases.
    Nam KH; Lee GJ; Kim JI; Song KH; Park J
    J Dermatol; 2023 Aug; 50(8):1093-1095. PubMed ID: 37334761
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic Contact Dermatitis Due to Minoxidil in a Patient with Alopecia Areata.
    Navarro-Triviño FJ; Pegalajar-García MD; Gil-Villalba A; Ruiz-Villaverde R
    Actas Dermosifiliogr; 2022 Dec; 113 Suppl 1():S8-S9. PubMed ID: 36543468
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Perret CM; Happle R
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata.
    Tavakolpour S; Mahmoudi HR; Daneshpazhooh M; Rahimzadeh G
    Scand J Immunol; 2016 Nov; 84(5):310-311. PubMed ID: 27500683
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone.
    Hoffmann R; Wenzel E; Huth A; van der Steen P; Schäufele M; König A; Happle R
    Acta Derm Venereol; 1996 Jan; 76(1):17-20. PubMed ID: 8721483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.